Literature DB >> 9507997

Regulation of caveolin and caveolae by cholesterol in MDCK cells.

D Hailstones1, L S Sleer, R G Parton, K K Stanley.   

Abstract

We have examined the expression of caveolin in MDCK cells under conditions that vary cellular cholesterol concentration. Caveolin mRNA levels dropped to one-sixth of control levels after treatment with simvastatin, an inhibitor of cholesterol synthesis, or beta-trimethyl cyclodextrin (CD), a cholesterol sequestering drug. Both simvastatin and CD treatment decreased total cellular cholesterol levels to about 50% of control values. The potent activator of the sterol regulatory element, 25-hydroxycholesterol, showed no direct regulation of caveolin mRNA levels. Caveolin protein concentration was also decreased to 50% of control values in cholesterol-depleted cells, giving rise to a severe attenuation of caveolin expression detected by indirect immunofluorescence labeling. Quantitative electron microscopy showed a total loss of morphologically recognizable invaginated caveolae after these cholesterol depletion treatments. When the number of invaginated caveolae per cell was expressed as a function of the cellular cholesterol content, a threshold phenomenon was observed, suggesting that caveolae only form when the steady state cellular cholesterol is above 50% of control values. These findings indicate that caveolins, and caveolae, may play an important part in cellular cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507997

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  89 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

3.  N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae.

Authors:  J B McCabe; L G Berthiaume
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

4.  Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways.

Authors:  Ramiro H Massol; Jakob E Larsen; Yukako Fujinaga; Wayne I Lencer; Tomas Kirchhausen
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

Review 5.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

6.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

7.  PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function.

Authors:  Michelle M Hill; Michele Bastiani; Robert Luetterforst; Matthew Kirkham; Annika Kirkham; Susan J Nixon; Piers Walser; Daniel Abankwa; Viola M J Oorschot; Sally Martin; John F Hancock; Robert G Parton
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

8.  Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking.

Authors:  Peter Thomsen; Kirstine Roepstorff; Martin Stahlhut; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

9.  Peptide-stimulation enhances compartmentalization and the catalytic activity of lung endothelial NOS.

Authors:  Tarun E Hutchinson; Sudeep Kuchibhotla; Edward R Block; Jawaharlal M Patel
Journal:  Cell Physiol Biochem       Date:  2009-11-04

10.  Caveolin-1 restoration by cholesterol enhances the inhibitory effect of simvastatin on arginine vasopressin-induced cardiac fibroblasts proliferation.

Authors:  Shaowei Liu; Yanping He; Yufeng Dou; Haichang Wang; Ling Tao; Lianyou Zhao; Fujun Shang; Hui Liu
Journal:  Mol Cell Biochem       Date:  2009-05-18       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.